Growth Metrics

Veracyte (VCYT) Equity Ratio (2016 - 2026)

Veracyte's Equity Ratio history spans 14 years, with the latest figure at 0.93 for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 2.97% to 0.93 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.93, a 2.97% increase, with the full-year FY2025 number at 0.93, up 2.97% from a year prior.
  • Equity Ratio hit 0.93 in Q4 2025 for Veracyte, up from 0.92 in the prior quarter.
  • Over the last five years, Equity Ratio for VCYT hit a ceiling of 0.95 in Q1 2021 and a floor of 0.9 in Q4 2024.
  • Historically, Equity Ratio has averaged 0.93 across 5 years, with a median of 0.93 in 2022.
  • Biggest five-year swings in Equity Ratio: rose 10.16% in 2021 and later fell 3.41% in 2024.
  • Tracing VCYT's Equity Ratio over 5 years: stood at 0.92 in 2021, then grew by 0.72% to 0.93 in 2022, then rose by 0.72% to 0.94 in 2023, then dropped by 3.41% to 0.9 in 2024, then rose by 2.97% to 0.93 in 2025.
  • Business Quant data shows Equity Ratio for VCYT at 0.93 in Q4 2025, 0.92 in Q3 2025, and 0.91 in Q2 2025.